Showing results (311-320 of 661) with videos related to
Sort By:
Pageof 67
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant AccrualChad Tang, Kenneth R Hess, Dwana Sanders, et al.Nursing Research|June 22, 2011
Use of Rasch analysis in the evaluation of the Oropharyngeal Mucositis Quality Of Life ScaleKaris K F Cheng, Jack Lee, S F Leung, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialAlan Pollack, Gunar K Zagars, George Starkschall, et al.Cancer Medicine|August 29, 2019
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancerBin Shi, Carmen Behrens, Viralkumar Vaghani, et al.Head & Neck|February 12, 2021
The tumor immune contexture of salivary duct carcinomaGustavo Schvartsman, Diana Bell, Maria Laura Rubin, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 11, 2017
Validation of diffusion tensor MRI measurements of cardiac microstructure with structure tensor synchrotron radiation imagingIrvin Teh, Darryl McClymont, Marie-Christine Zdora, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokersLi Zhang, J Jack Lee, Hongli Tang, et al.BMC Cancer|October 27, 2011
Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trialCatherine F Poh, J Scott Durham, Penelope M Brasher, et al.JNCI Cancer Spectrum|June 21, 2019
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung CancerJennifer S Davis, Erin Prophet, Ho-Lan Peng, et al.Molecular Cancer Therapeutics|July 11, 2007
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasionAnne S Tsao, Dandan He, Babita Saigal, et al.Pageof 67